ArticleFrontiers in immunology2018

NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.

Andrew Leber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.